BR100 Decreased By (-1.22%)
BR30 Decreased By (-1.43%)
KSE100 Decreased By (-1.03%)
KSE30 Decreased By (-1.12%)
AGHA 7.72 Decreased By ▼ -0.09 (-1.15%)
BECO 5.11 Decreased By ▼ -0.10 (-1.92%)
BML 57.00 Decreased By ▼ -0.50 (-0.87%)
BOP 33.80 Decreased By ▼ -0.23 (-0.68%)
CNERGY 9.86 Decreased By ▼ -0.10 (-1%)
CSIL 5.29 Decreased By ▼ -0.02 (-0.38%)
FCCL 52.88 Decreased By ▼ -1.82 (-3.33%)
FFL 16.53 Decreased By ▼ -0.16 (-0.96%)
FNEL 1.21 Decreased By ▼ -0.02 (-1.63%)
KEL 7.20 Decreased By ▼ -0.20 (-2.7%)
KOSM 5.74 Decreased By ▼ -0.03 (-0.52%)
LOTCHEM 29.10 Decreased By ▼ -0.22 (-0.75%)
MLCF 91.80 Decreased By ▼ -2.56 (-2.71%)
NBP 201.34 Decreased By ▼ -1.71 (-0.84%)
NCPL 56.30 Decreased By ▼ -0.70 (-1.23%)
NPL 66.68 Decreased By ▼ -1.02 (-1.51%)
OGDC 313.00 Decreased By ▼ -2.84 (-0.9%)
PACE 10.50 Decreased By ▼ -0.14 (-1.32%)
PAEL 41.98 Decreased By ▼ -1.22 (-2.82%)
PIBTL 16.40 Decreased By ▼ -0.34 (-2.03%)
PPL 215.40 Decreased By ▼ -4.38 (-1.99%)
PRL 50.30 Increased By ▲ 1.11 (2.26%)
PTC 69.57 Decreased By ▼ -0.96 (-1.36%)
SSGC 27.00 Decreased By ▼ -1.25 (-4.42%)
TBL 9.80 Decreased By ▼ -0.06 (-0.61%)
TELE 8.65 Decreased By ▼ -0.14 (-1.59%)
TPL 18.14 Decreased By ▼ -0.10 (-0.55%)
TPLP 13.42 Increased By ▲ 0.15 (1.13%)
TREET 22.50 Decreased By ▼ -0.22 (-0.97%)
TRG 59.20 Decreased By ▼ -0.94 (-1.56%)

ISLAMABAD: Philippine Ambassador to Pakistan Dr Emmanuel R Fernande said the opening of a Philippine pharmaceutical company’s subsidiary in Islamabad reflected increasing investor confidence in Pakistan and marked a positive development in expanding bilateral trade and healthcare cooperation between the two countries.

Speaking at the inauguration ceremony of 2World Traders Pakistan, the ambassador said the establishment of a Philippine-registered pharmaceutical firm in Pakistan created new opportunities for collaboration in pharmaceuticals, vaccines, supply chains and healthcare services.

He noted that vaccines and biological products were critical components of resilient health systems and said private-sector initiatives could contribute meaningfully to public health while strengthening economic linkages.The Islamabad office was inaugurated by Abdul Razzaq Siddiq, Owner of 2World Traders Pakistan and President of Philippines-based 2World Traders Inc. The ceremony was attended by Dr Imran Yusuf, Honorary Consul General of the Philippines in Karachi; Dr Obaid Ullah, Chief Executive Officer of the Drug Regulatory Authority of Pakistan (DRAP); representatives of Shifa International Hospital, the National University of Sciences and Technology (NUST) and the Dow Institute of Life Sciences (DILS), along with senior business and industry figures.

Addressing the gathering, Dr Obaid Ullah emphasized the importance of regulatory cooperation and harmonization to facilitate pharmaceutical trade while ensuring compliance with international quality and safety standards.

In his remarks, Abdul Razzaq Siddiq said the company aimed to support Pakistan’s healthcare sector by improving access to essential vaccines and biological products, promoting technology transfer and encouraging local manufacturing. He announced plans to import key vaccines, including Tetanus Toxoid, with an initial shipment of 10 million doses to help ease supply constraints.

He added that future initiatives included the local production of anti-rabies serum in collaboration with DILS, as well as the development of anti-cancer medicines and anti-snake venom serum, particularly for underserved areas of Sindh and Balochistan.

Founded in 1988, 2World Traders Inc. is a distributor of vaccines and biological products in the Philippines, with operations across Asia, the Middle East, Europe and North America, supported by cold-chain infrastructure and manufacturing collaborations in India and China.

The opening of the Islamabad office is expected to contribute to enhanced trade flows, regulatory coordination and healthcare collaboration between Pakistan and the Philippines, while supporting broader foreign investment inflows.

Copyright Business Recorder, 2026

Comments

Comments are closed for this article.